The clinical treatment of thrombocytopenia is very limited, such as reducing the dose of chemotherapy or chemoradiotherapy drugs, delaying chemotherapy or chemoradiotherapy, performing platelet transfusion, and administering recombinant human interleukin-11 (rhIL-11) and recombinant human thrombopoietin (rhTPO). Here, THPO is linked to Thrombocytopenia.